Ad
BMY - Bristol Myers Squibb Company Stock Trading
About | Bristol-Myers Squibb Company (NYSE:BMY)
Not available
Quote | Bristol-Myers Squibb Company (NYSE:BMY)
| Last: | $64.80 |
|---|---|
| Change Percent: | -0.09% |
| Open: | $65.37 |
| Close: | $64.80 |
| High: | $65.46 |
| Low: | $64.6 |
| Volume: | 7,067,902 |
| Last Trade Date Time: | 06/09/2023 03:00:00 am |
News | Bristol-Myers Squibb Company (NYSE:BMY)
-
2023-06-09 09:26:24 ET The Biden administration on Friday published a list of Medicare Part B drugs that will be subject to inflation penalties for Q3 2023, including some of the products from AbbVie ( NYSE: ABBV ) and Amgen ( NASDAQ: AMGN ) in the list of 43 medications. ...
-
2023-06-08 23:21:36 ET Summary The article analyzes Amgen's financial performance, including balance sheet trends, valuation models, and competition & margin trends. We'll discuss AMGN's dividend and free cash flow of this large, very well-covered dividend growth stock. Am...
Message Board Posts | Bristol-Myers Squibb Company (NYSE:BMY)
| Subject | By | Source | When |
|---|---|---|---|
| whytestocks: $BMY News Article - U.S. FDA Accepts for Priority Review Supplemental Biologics License | whytestocks | investorshangout | 05/01/2023 6:30:47 PM |
| whytestocks: $BMY News Article - Bristol Myers Squibb's TRANSCEND FL and TRANSCEND NHL 001 Studies o | whytestocks | investorshangout | 05/01/2023 6:25:58 PM |
| $BMY 1Q23 CC transcript: | DewDiligence | investorshub | 04/28/2023 1:04:44 PM |
| $BMY 1Q23 results | DewDiligence | investorshub | 04/27/2023 11:56:28 AM |
| $BMYs$ CCO, Christopher Boerner>CEO effective 11/1/23: | DewDiligence | investorshub | 04/26/2023 8:43:15 PM |
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
